Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Melero

Showing results (81-90 of 351) with videos related to

Pageof 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2025
Facts and hopes in harnessing macrophage-mediated antibody-dependent cellular phagocytosis for cancer immunotherapyMaria Armero, Manuel Smolkin, Mario Garcia-Dominguez, et al.
Nature Reviews. Drug Discovery|September 8, 2018
An RNA toolbox for cancer immunotherapyFernando Pastor, Pedro Berraondo, Iñaki Etxeberria, et al.
Trends in Immunology|July 14, 2018
Immunological Mechanisms Responsible for Radiation-Induced Abscopal EffectMaría E Rodríguez-Ruiz, Claire Vanpouille-Box, Ignacio Melero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2013
Agonist antibodies to TNFR molecules that costimulate T and NK cellsIgnacio Melero, Daniel Hirschhorn-Cymerman, Aizea Morales-Kastresana, et al.
Contrast Media & Molecular Imaging|December 31, 2013
Cell tracking using multimodal imagingMangala Srinivas, Ignacio Melero, Eckhart Kaempgen, et al.
Cancer Discovery|December 28, 2022
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th AnniversaryIgnacio Melero, Miguel F Sanmamed, Javier Glez-Vaz, et al.
Cells|October 14, 2022
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells ActivityAlberto Mendoza-Valderrey, Maite Alvarez, Andrea De Maria, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2016
Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage?Bettina Weigelin, Elixabet Bolaños, Maria E Rodriguez-Ruiz, et al.
Plos One|November 22, 2007
A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseasesRicardo Palacios, Joaquin Goni, Ivan Martinez-Forero, et al.
Current Opinion in Immunology|February 4, 2014
Orchestrating immune check-point blockade for cancer immunotherapy in combinationsJose Luis Perez-Gracia, Sara Labiano, Maria E Rodriguez-Ruiz, et al.
Pageof 36

Showing results (81-90 of 351) with videos related to

Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2025
Facts and hopes in harnessing macrophage-mediated antibody-dependent cellular phagocytosis for cancer immunotherapyMaria Armero, Manuel Smolkin, Mario Garcia-Dominguez, et al.
Nature Reviews. Drug Discovery|September 8, 2018
An RNA toolbox for cancer immunotherapyFernando Pastor, Pedro Berraondo, Iñaki Etxeberria, et al.
Trends in Immunology|July 14, 2018
Immunological Mechanisms Responsible for Radiation-Induced Abscopal EffectMaría E Rodríguez-Ruiz, Claire Vanpouille-Box, Ignacio Melero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2013
Agonist antibodies to TNFR molecules that costimulate T and NK cellsIgnacio Melero, Daniel Hirschhorn-Cymerman, Aizea Morales-Kastresana, et al.
Contrast Media & Molecular Imaging|December 31, 2013
Cell tracking using multimodal imagingMangala Srinivas, Ignacio Melero, Eckhart Kaempgen, et al.
Cancer Discovery|December 28, 2022
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th AnniversaryIgnacio Melero, Miguel F Sanmamed, Javier Glez-Vaz, et al.
Cells|October 14, 2022
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells ActivityAlberto Mendoza-Valderrey, Maite Alvarez, Andrea De Maria, et al.
Cancer Immunology, Immunotherapy : CII|March 14, 2016
Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage?Bettina Weigelin, Elixabet Bolaños, Maria E Rodriguez-Ruiz, et al.
Plos One|November 22, 2007
A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseasesRicardo Palacios, Joaquin Goni, Ivan Martinez-Forero, et al.
Current Opinion in Immunology|February 4, 2014
Orchestrating immune check-point blockade for cancer immunotherapy in combinationsJose Luis Perez-Gracia, Sara Labiano, Maria E Rodriguez-Ruiz, et al.
Pageof 36